Positive allosteric binding behavior of pyrene-appended triazole-modified thiacalix[4]arene-based fluorescent receptors by Redshaw, Carl. et al.
  Elsevier Editorial System(tm) for Tetrahedron    Manuscript Draft 
Manuscript Number: TET-D-14-01329R2 Title: Positive allosteric binding behaviour of pyrene-appended triazole-modified thiacalix[4]arene-based fluorescent receptors Article Type: Full Length Article Corresponding Author: Prof. Takehiko Yamato, Ph.D. Corresponding Author's Institution: Saga University First Author: Hirotsugu Tomiyasu, MD Order of Authors: Hirotsugu Tomiyasu, MD; Naoki Shigyo, BC; Xin–Long Ni, Ph.D.; Xi Zeng, Ph.D.; Carl Redshaw, Ph.D.; Takehiko Yamato, Ph.D. Abstract: The novel heteroditopic receptors 5a~c have been synthesized, which bear a thiacalix[4]arene in the 1,3-alternate conformation. Two urea moieties possessing various aryl groups with either electron-donating or -withdrawing groups at their p-positions function as anion-binding sites. At the opposite side of the cavity are two pyrene-appended triazole rings, which act as cation-binding sites. The binding property of receptor 5c was investigated by means of 1H NMR and UV-vis spectroscopy and by fluorescence titration experiments in the presence of various transition metal cations and anions in CH2Cl2-DMSO (10:1, v/v) solution. Interestingly, it was found that receptor 5c possessing two p-nitrophenyl ureido moieties, most efficiently complexes in the urea cavity or bistriazoles; the plausible allosteric effect of receptor 5c was also investigated. 
© 2014, Elsevier. Licensed under the Creative Commons Attribution-NonCommercial-
NoDerivatives 4.0 International http://creativecommons.org/licenses/by-nc-nd/4.0/
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Graphical Abstract 
To create your abstract, type over the instructions in the template box below. 
Fonts or abstract dimensions should not be changed or altered. 
Positive allosteric binding behaviour of  
pyrene–appended triazole–modified thiacalix[4]arene
–based fluorescent receptors
Hirotsugu Tomiyasua, Naoki Shigyoa, Xin–Long Nib, Xi Zengb,
Carl Redshawc, Takehiko Yamatoa,* 
a Department of Applied Chemistry, Faculty of Science and Engineering, Saga University, Honjo-machi 1, Saga 
840-8502, Japan
b Key Laboratory of Macrocyclic and Supramolecular Chemistry of Guizhou Province, Guizhou 
University,Guiyang 550025, People’s Republic of China
c Department of Chemistry, The University of Hull, Cottingham Road, Hull, Yorkshire, HU6 7RX, UK 
Leave this area blank for abstract info. 
*Revised Manuscript ( Including Graphical Abstract )
Click here to view linked References
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Tetrahedron 1 
 
 
Tetrahedron 
journal  homepage:  www.e lsevier .com  
 
Positive allosteric binding behaviour of pyrene–appended triazole–modified 
thiacalix[4]arene–based fluorescent receptors 
Hirotsugu Tomiyasua, Naoki Shigyoa, Xin–Long Nib, Xi Zengb, Carl Redshawc, Takehiko Yamatoa,* 
a Department of Applied Chemistry, Faculty of Science and Engineering, Saga University, Honjo-machi 1, Saga 840-8502, Japan 
b Key Laboratory of Macrocyclic and Supramolecular Chemistry of Guizhou Province, Guizhou University,Guiyang 550025, People’s Republic of China 
c Department of Chemistry, The University of Hull, Cottingham Road, Hull, Yorkshire, HU6 7RX, UK 
 
1. Introduction 
The investigation of macrocycles such as calix[n]arenes1 
which are attractive building blocks for creating host systems 
capable of selectively recognizing cation, anion or neutral 
molecules has become an active area of research in 
supramolecular chemistry. Thiacalix[4]arenes2,3 which are 
sulfur–bridged analogs of calix[4]arenes are excellent scaffolds 
and have been utilized in chemosensors, supramolecular self-
assemblies and the catalytic activity of enzymes. A large 
number of enzymes have allosteric sites to control catalytic 
activity by stabilizing the active conformation. Many systems 
based on thiacalix[4]arenes are capable of host–guest 
interactions and involve conformational changes caused by the 
allosteric binding4 of metal cations, and these relate to the 
maintenance of the essential material balance necessary for life. 
Anions also have been widely employed in biological, 
environmental and industrial processes.5 The development of 
anion selective sensors6 based on calix[n]arenes has received a 
considerable amount of attention in the area of supramolecular 
chemistry. Calix[n]arene urea derivatives are extremely 
prominent and are efficient for anion complexations via the N– 
 
* Corresponding author. Fax: +81 952 28 8548; e-mail address: yamatot@cc.saga-u.ac.jp        
(T. Yamato). 
H protons due to the formation of hydrogen bonds.7,8 Click 
chemistry9 is one of the most useful and widely employed 
reactions in synthetic chemistry. In particular, the Cu(I)–
catalyzed azide–alkyne cycloaddition reaction is a highly 
versatile method which can be performed in high yield under 
very mild conditions. The 1,4–disubstituted–1,2,3–triazole 
products can act as relatively stable functional groups as 
covalent linkers or as ligands for metal cations, and have been 
utilized in the fields of drug discovery and materials science. 
Recently, many calix[n]arene derivatives bearing 1,4–
disubstituted–1,2,3–triazoles as linking groups have been 
developed and investigated.10 
Chung11 and co–workers reported a fluorescent 
chemosensor bearing a calix[4]arene in a 1,3–alternate 
conformation, which contains two anthracene–appended 
triazole rings and the crown–ether moiety.11a This receptor 
exhibited a negative allosteric effect between the Pb2+ and K+ 
ions in common organic solvents. Moreover, they also reported 
that a homobinuclear ditopic fluorescent chemosensor bearing a 
1,3-alternate calix[4]arene, which contained two anthracene–
appended triazole rings and two phenylenaminones at the 
opposite sides of the calix[4]arene cavity.11d This receptor 
exhibited a positive allosteric effect between two equivalents of 
Ag+ ion in common organic solvents. However, investigations 
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electron–donating or –withdrawing groups at their p–positions function as anion–binding sites. 
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in the urea cavity or bistriazoles; the plausible allosteric effect of receptor 5c was also 
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concerning the appearance of allosteric effects in analogues 
based on thiacalix[4]arenes/metal cations/anions has not yet 
been reported. Herein, we have independently designed a 
heterodimeric system12 based on a thiacalix[4]arene having two 
different side arms. Specifically, we have incorporated two 
ureas moieties which link various phenyl groups substituted 
with the electron–donating or –withdrawing groups at the p–
positions and two pyrene–appended triazole rings at the 
opposite side of thiacalix[4]arene cavity. We built up the 
hypothesis that the heterodimeric system, which is controlled by 
the complexation of the opposite side arms with Cl– and Ag+ 
ions, exhibits an effective positive allosteric effect. 
2. Results and discussion 
2.1. Synthesis 
O-Alkylation of distal-1 was carried out with 10 equiv. of  
propargyl bromide in the presence of 10 equiv. of Cs2CO3 according 
to the reported procedure to afford the desired 1,3–alternate–2 in 
85 % yield.12 A Cu(I)–catalyzed 1,3–dipolar cycloaddition reaction 
of 1,3–alternate–2 with 4 equiv. of 1–azidomethylpyrene via Click 
chemistry was carried out according to the reported procedure, and 
afforded the 1,2,3–triazole thiacalix[4]arene 1,3–alternate–3 in 48 % 
yield. The hydrazinolysis of 1,3–alternate–3 was carried out with a 
large excess of hydrazine hydrate to afford the desired 1,3–
alternate–4 in 86 % yield. The condensation of 1,3–alternate–4 with 
4 equiv. of the appropriate isocyanate in THF furnished the receptors 
5a~c in good yield (Scheme 1). In general, the 1H NMR spectra of 
receptors 5a~c in CDCl3–DMSO (10:1, v/v) exhibited the 
characteristics of a 1,3–alternate canformation, viz two singlets (18H 
each) for the tert-butyl protons, one singlet (4H) for OCH2CO 
protons, one singlet (4H) for OCH2–triazole protons, two singlets 
(4H each) for aromatic protons, two singlets (2H each) for four urea 
NH protons and one singlet (2H) for triazole–H protons. Moreover, a 
concentration dependence of the 1H NMR chemical shifts of the 
ureido protons in receptor 5c was not observed (Figure S13). This 
result suggests that receptor 5c has a strong intramolecular hydrogen  
 
 
Scheme 1 Synthesis of receptors 1,3-alternate-5a~c. 
Table 1 Association constantsa of  receptor 5a~c with Cl– ionb                                       
a Measured in CH2Cl2–DMSO (10:1, v/v) at 27 °C by fluorescence 
titration experiments (Figures S15–S21); host concentration was 1.0 
μM. b Guests used: Bu4NCl. 
 
 
bond between the two ureas moieties.  
 
2.2. Binding studies 
Upon addition of Cl– ion (0–20 PM) to a solution of receptor 5c 
(1.0 PM), Figure S19 shows that both the monomer and excimer 
emissions of the pyrene units gradually decrease. A Job’s plot 
binding between receptor 5c and Cl– ion reveals a 1:1 stoichiometry 
(Figure S20), while the association constant (Ka value) for the 
complexation with Cl– ion by receptor  5c was determined to be 
42500 ± 2975 M-1 as determined by the fluorescence titration 
experiment in CH2Cl2–DMSO (10:1, v/v) (Figure S21 and Table 1). 
Moreover, Ka values between the receptors 5a~b and Cl– ion were 
determined by analyzing fluorescence titration experiments, 
respectively (Figures S15–S18 and Table 1). These results suggest 
that the association constants depend on the electron–
donating/withdrawing groups located at the p–position. In the 
presence of the electron–withdrawing group NO2 (receptor 5c), the 
Ka value was greater than that for the unsubstituted receptor (receptor 
5a). In contrast, in the case of receptor 5b, with the electron–donating 
Me group, there was a general decrease in the Ka value for the 
complexation with Cl– ion in comparison to the case in the 
unsubstituted receptor 5a. Therefore, the introduction of electron–
withdrawing groups at the p–position appears to increase the acidity 
of the urea protons, and hence enhance the anion–binding ability 
through hydrogen–bonding interactions. The Ka value of receptor 5c 
with the electron–withdrawing NO2 group at the p–position was the 
best out of all the Ka values between receptors 5a~c and Cl– ion. From  
 
 
 
Fig. 1 Fluorescence spectral changes of receptor 5c (1.0 PM) upon addition of 
various tested anions (1.0 μM) in CH2Cl2–DMSO (10:1, v/v). λex = 343 nm. 
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Fig. 2 Binding mode of receptor 5c upon addition of Cl– ion at 298 K as a 
tetrabutylammonium (TBA) salt and partial 1H NMR spectra of 5c (4.0 mM) 
in CDCl3–DMSO–CH3CN (10:1:1, v/v) upon addition of Ag+ ion at 298 K. 
 
 
the above, we can say that the receptor 5c, with the electron– 
withdrawing NO2 group at the p–position, has the most effective 
recognition ability toward selected anions of the systems screened 
herein. Given this, complexation studies of receptor 5c toward 
targeting various transition metal cations and anions were carried out 
using 1H NMR and UV–vis spectroscopy and by fluorescence 
titration experiments.  
The UV–vis absorption spectra of receptor 5c (1.0 μM) were 
recorded in the presence of various anions (20 equiv.) in CH2Cl2–
DMSO (10:1, v/v) as shown in Figure S14. The receptor 5c (1.0 
μM)exhibits an absorption band at 347 nm in the UV–vis absorption 
spectra in the absence of anions. Interestingly, significant changes 
moving to a longer wavelength in absorption spectra were observed 
in the presence of F–, AcO–, PhCOO– or H2PO4– with a color change 
from colourless to dark yellow by the naked eye, respectively. These 
results suggest that the quinoid structure was formed by the 
deprotonation of the urea NH groups in the p–nitrophenyl ureido 
moiety. Figure 1 reveals the fluorescence intensity changes of the 
monomer (393 nm) and excimer (486 nm) emissions for receptor 5c 
in the presence of various anions. Receptor 5c exhibited a decrease in 
intensity of both the monomer and excimer emissions with various 
anions. Upon addition of Cl– ion to a solution of receptor 5c, the 
decrease of intensity of the monomer emission is presumably caused 
by a photo–induced electron transfer (PET) mechanism which  
Fig. 3 Fluorescence spectral changes of receptor 5c (1.0 PM) to upon addition 
of various tested metal cations (20 μM) in CH2Cl2–DMSO (10:1, v/v). λex = 
343 nm. 
 
 
Fig. 4 Fluorescence response of receptor 5c (1.0 PM) in CH2Cl2–DMSO (10:1, 
v/v) to various tested metal cations (20 μM) (blue bar) and to the mixture of 
tested metal ions (20 μM) with Ag+ ion (20 μM) (red bar) at 298 K. Io is the 
fluorescence intensity at 393 nm for free receptor 5c, and I is the fluorescence 
intensity after adding metal ions with an excitation at 343 nm. 
 
 
operates from the oxygen of the urea moiety which complexes with 
the Cl– ion via hydrogen bonding to the pyrene moieties. By contrast, 
upon addition of F–, AcO–, PhCOO– or H2PO4– ions to a solution of 
receptor 5c, the decreasing intensity of the monomer emission is 
caused by deprotonation of the urea NH groups which induces a PET 
mechanism from the anionic nitrogen to the pyrene moieties. On the 
other hand, upon addition of F–, Cl–, AcO–, PhCOO– or H2PO4– ions 
to a solution of receptor 5c, the decreasing intensity of the excimer 
emission is caused by conformational unstacking of two pyrene ureas, 
which breaks down an intramolecular π–π interaction because of 
complex formation. As shown in Figure 2, the signals for the NHa 
protons (red) progressively shifted downfield by 0.64 ppm (δ = 8.98 
to 9.62 ppm) until one equiv. of Cl– ion was added. On the other 
hand, the signals for the NHb protons (blue) progressively shifted 
upfield by 0.09 ppm (δ = 8.50 to 8.41 ppm) until one equiv. of Cl– 
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Fig. 5 Binding mode of receptors 5c upon complexation with Ag+ ion as 
trifluoromethanesulforic salt, and partial 1H NMR spectra of receptors 5c (4.0 
mM) in CDCl3–DMSO–CD3CN (10:1:1, v/v) upon addition of Ag+ ion (1.0 
equiv.) at 298 K. 
 
 
ion was added. These results strongly suggested Cl– ion recognition 
by receptor 5c via a hydrogen–bonding interaction between Cl– ion 
and N–H protons as shown in Figure 2 and Figure S32. The 
fluorescence intensity changes of receptor 5c were recorded in 
CH2Cl2–DMSO (10:1, v/v) in the presence of a 20–fold excess of 
various metal cations and their fluorescence spectra thus obtained 
were compared with that recorded in the absence of metal cations 
under similar experimental conditions. It was observed that both the 
monomer and excimer emissions of receptor 5c were strongly 
quenched by Cu2+ and Hg2+ ions in Figure 3. The fluorescence 
titration behaviour was evaluated in the case of receptor 5c with Cu2+ 
and Hg2+ ions (Figures S22–S25). From these observations, the 
association constants for complexation were calculated to be: 5c·Cu2+ 
= 330000±23100 M-1, 5c·Hg2+ = 420000±29400 M-1, respectively. 
In contrast, upon addition of Ag+ ion into a solution of receptor 5c, 
the fluorescence monomer emission was enhanced, while the 
excimer emission decreased. As shown in Figue 4, competitive 
experiments were carried out in the presence of Ag+ ion (20 μM) 
mixed with other metal cations (20 μM). These results suggested that 
the receptor 5c exhibits selective fluorescent behaviour towards the 
Ag+ ion. Upon addition of Ag+ ion (0–20 PM) to a solution of 
receptor 5c (1.0 PM), Figure S26 shows the excimer emission of the 
pyrene units (486 nm) dicreases and the monomer emission of the 
pyrene units (393 nm) increases. This is because the complexation of 
Ag+ ion by receptor 5c induces the conformational unstacking of two 
pyrene ureas resulting in quenching of an intramolecular π–π 
interaction. Meanwhile, a discernible isoemissive point was observed 
at 445 nm. A Job’s plot binding between receptor 5c and Ag+ ion 
reveals a 1:1 stoichiometry (Figure S27), while the association 
constant (Ka) for the complexation with Ag+ ion by receptor  5c was 
determined to be 61975 ± 4336 M-1 as determined by the 
fluorescence titration experiment in CH2Cl2–DMSO (10:1, v/v) 
(Figure S28). The fluorescent titration profile for receptor 5c with 
Ag+ ion demonstrated that the detection limit of Ag+ ion was 1.92 × 
10-7 M (Figure S29). As a result, receptor 5c can be regarded as being 
highly sensitive to the Ag+ ion, especially given the large 
fluorescence dynamic range and the low detection limit of 1.92 × 10-
7 M. The quantum yield of the free receptor 5c is Φ = 0.11, for both 
the monomer and excimer emission (393 and 486 nm). The quantum 
yield of the receptor 5c•Ag+ complex is Φ = 0.06 as a result of 
increased monomer emission. To elucidate the complexation 
behaviour of receptors 5c with Ag+ ion in detail, 1H NMR 
spectroscopic titration experiments in CDCl3–DMSO–CH3CN 
(10:1:1, v/v) were carried out. Upon addition of 1.0 equiv. of Ag+ ion 
to the solution of receptors 5c, a large downfield shift of 1.08 ppm (δ 
= 6.72 to 7.80 ppm) for the proton Hh on the triazole ring was 
observed, together with a downfield shift of 0.20 ppm (δ = 4.32 to 
4.52 ppm) for the proton Hg on the OCH2-triazole unit and a 
downfield shift of 0.17 ppm (δ = 7.33 to 7.50 ppm) for the proton Hf 
on the aromatic protons of thiacalix[4]arene cavity; the chemical 
shifts of the NH protons did not change. This result suggested that 
the Ag+ ion can be selectively bound by the nitrogen atoms on the 
triazole rings and is included in the π–basic benzene cavity at the 
lower rim. The two distal benzene rings were flattened and the 
residual two benzene rings were standing upright for the binding of 
the Ag+ ion as shown in Figure 5. On the basis of the above, we 
investigated the appearance of an allosteric effect by the 
complexation of the opposite side arms with Cl– and Ag+ ions by 1H 
NMR spectroscopic and fluorescence titration experiments. The 
result of the fluorescence titration experiments of receptor 5c• Cl– 
with Ag+ ion are shown in Figure S33. When increasing 
concentrations of Ag+ ion were added to a solution of receptor 5c•
Cl–, the fluorescence intensity of the monomer (393 nm) and excimer 
(486 nm) emissions of pyrene gradually increased because of an 
allosteric effect via an ion-pair electrostatic interaction and a 
conformational change of the flexible thiacalix[4]arene cavity. 
Further addition of more than 1.0 equiv. of Ag+ ion led to a 
significant increase in the monomer emission of the pyrene units, 
while the accompanying excimer emission reached a plateau upon 
adding about 20 equiv of Ag+ ion. The association constant of 
receptor 5c• Cl– with Ag+ ion was determined to be 325000±22750 
M-1 by the fluorescence titration experiment in CH2Cl2–DMSO (10:1, 
v/v) (Figure S34). The results indicated that receptor 5c• Cl– was 
complexed with the Ag+ ion at two pyrene–appended triazole 
rings by a positive allosteric effect because the complexation with 
Cl– ion in the urea cavity caused an ion-pair electrostatic interaction 
and a conformational change of the flexible thiacalix[4]arene cavity. 
The fluorescent titration profile for receptor 5c• Cl– with Ag+ ion 
demonstrated that the detection limit of Ag+ ion was 1.02 × 10-8 M 
(Figure S35). As a result, in comparison to the case in the free 
receptor 5c to the Ag+ ion (1.92 × 10-7 M), receptor 5c• Cl– can be 
regarded as being more highly sensitive to the Ag+ ion. To 
investigate further the possible appearance of an effective allosteric 
effect between receptor 5c• Cl– and the Ag+ ion, 1H NMR titration 
experiments in CDCl3–DMSO–CD3CN (10:1:1, v/v) were conducted. 
When only Cl– ion was added, it was observed that the signal for the 
NHa protons shifted downfield, while the signal for NHb protons 
shifted upfield. However, the signals of the protons on the two 
pyrene–appended triazole ring moieties did not shift (Figures 6a 
and 6b). This result suggests a Cl– ion recognition of receptor 5c by a 
hydrogen–bonding interaction between the Cl– ion and N–H protons.  
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Fig. 6 Proposed positive allosteric behaviour of receptor 5c with Cl– and Ag+ 
ions. Partial 1H NMR spectra of 5c /guest (H/G = 1:1); a) free 5c; b) 
5cBu4NCl; c) AgSO3CF3[5cCl–]; d) 5cAgSO3CF3. Solvent: CDCl3–
DMSO–CD3CN (10:1:1, v/v). 300 MHz at 298 K. *Denoted the solvent peak. 
 
 
Furthermore, when Ag+ ion was added to a solution of [5cBu4NCl] 
(Figure 6c), this addition induced a large downfield shift of 1.22 ppm 
(δ = 6.72 to 7.94 ppm) for the proton Hh on the triazole ring, a 
downfield shift of 0.18 ppm (δ = 4.32 to 4.50 ppm) for the proton Hg 
on the OCH2–triazole unit and a downfield shift of 0.15 ppm (δ = 
7.33 to 7.48 ppm) for the proton Hf of the aromatic protons of 
thiacalix[4]arene cavity. The chemical shifts for all NH protons did 
not change. These results suggested the formation of a heterogeneous 
dinuclear complex Ag+[5cCl–] (Figure 6c), and we propose a 
positive allosteric effect for receptor 5c toward the Ag+ ion in the 
presence of the Cl– ion as shown in Figure 6.  
3. Conclusion 
In summary, the novel heteroditopic receptors 5a~c bearing a 
thiacalix[4]arene in a 1,3–alternate conformation have been 
synthesized. These receptors possess two ureas moieties linking 
various aryl groups bearing electron–donating or –withdrawing 
substituents at their p–positions which act as anion–binding 
sites and two pyrene–appended triazole rings which act as 
cation–binding sites at the opposite side of thiacalix[4]arene 
cavity. Furthermore, we have shown that two ureas moieties can 
bind various anions having a wide range of geometries based on 
UV–vis absorption, fluorescence and 1H NMR titration experiments. 
We have also shown that the triazole groups can bind Ag+, Hg2+ and 
Cu2+ ions based on both fluorescence spectroscopy and 1H NMR 
titration experiments. Upon addition of Hg2+ and Cu2+ ions to a 
solution of receptor 5c in CH2Cl2–DMSO (10:1, v/v), the 
fluorescence spectrum was strongly quenched because of a reverse 
PET from the pyrene moieties to the triazole groups. By contrast, 
upon addition of Ag+ ion to a solution of receptor 5c in CH2Cl2–
DMSO (10:1, v/v), the fluorescence monomer emission was 
enhanced, while the excimer emission declined because of the 
complexation of the Ag+ ions with the triazole groups. Interestingly, 
the fluorescence of receptor 5c was quenched by Cl– ion, but could 
be revived by the addition of Ag+ ion to the receptor 5c• Cl– 
complex. The appearance of a positive allosteric effect in receptor 5c 
was investigated based on fluorescence and 1H NMR titration 
experiments. Interestingly, the formation of heterogeneous dinuclear 
complex Ag+[5cCl–] of receptor 5c with Cl– and  Ag+ ions by a 
positive allosteric effect could be observed.  
 
4. Experimental section 
4.1 General  
Unless otherwise stated, all reagents used were purchased 
from commercial sources and were used without further 
purification. Compounds 1,13 212e and 312e were prepared 
following the reported procedures. All solvents used were dried 
and distilled by the usual procedures prior to use. All melting 
points (Yanagimoto MP-S1) are uncorrected. 1H NMR and 13C 
NMR spectra were recorded on a Nippon Denshi JEOL FT-300 
NMR spectrometer and Varian-400MR-vnmrs400 with SiMe4 as 
an internal reference: J-values are given in Hz. IR spectra were 
measured for samples as KBr pellets on a Nippon Denshi JIR-
AQ2OM spectrophotometer. Mass spectra were obtained with a 
Nippon Denshi JMS-HX110A Ultrahigh Performance mass 
spectrometer at 75 eV by using a direct-inlet system. UV-vis 
spectra were recorded using a Shimadzu UV-3150UV-vis-NIR 
spectrophotometer. Fluorescence spectroscopic studies of 
compounds in solution were performed in a semimicro 
fluorescence cell (Hellma®, 104F-QS, 10 × 4 mm, 1400 μL) with 
a Varian Cary Eclipse spectrophotometer. Fluorescence quantum 
yields were recorded in solution (Hamamatsu Photonics K. K. 
Quantaurus-QY A10094) using the integrated sphere absolute PL 
quantum yield measurement method. Elemental analyses were 
performed by a Yanaco MT-5.The elemental analysis, MS, and 
emission spectra were measured. 
4.2. Materials 
4.2.1. Synthesis of compound 4. Compound 3 (300 mg, 
0.202 mmol) was put into a round-bottom flask and ethanol 
(50 mL), THF (50 mL) and hydrazine hydrate (6 mL, large 
excess) were added and the system was refluxed for 24 h. 
After cooling, the solvents and excess hydrazine were 
removed under reduced pressure to give the crude product as 
a white solid. The residue was triturated sequentially with 
water and methanol and the product collected by filtration. 
The residue was adsorbed in silica gel and purified by 
column chromatography using ethyl acetate as eluent and 
washed with hexane to give receptor 4a (253 mg, 86 %) as a 
white solid. M.p. 157–161 °C. IR: Xmax (KBr)/cm-1: 3422, 
3322, 2869, 1677, 1623, 1590, 1432, 1381, 1362, 1266, 
1239, 1087, 1045, 970, 817 and 708. 1H NMR (400 MHz, 
CDCl3): δ = 0.95 (18H, s, tBu × 2), 0.99 (18H, s, tBu × 2), 
3.49 (4H, br, NH2 × 2), 4.29 (4H, s, OCH2–triazole × 2), 5.06 
(4H, s, OCH2CO × 2), 6.29 (4H, s, CH2–pyrene × 2), 6.69 
(2H, s, Triazole–H × 2), 7.07 (4H, s, Ar–H × 2), 7.26 (4H, s, 
Ar–H × 2), 7.36 (2H, s, NH × 2) and  7.86–8.33. (18H, m, 
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Pyrene–H × 18) ppm. 13C NMR (100 MHz, CDCl3): δ = 
30.7 (CH3), 30.8 (CH3), 33.9 (C(CH3)3), 51.8 (CH2), 62.6 
(OCH2), 68.3 (OCH2), 122.2 (ArC), 122.9 (ArC), 124.2 
(ArC), 124.6 (ArC), 124.7 (ArC), 125.5 (ArC), 125.6 (ArC), 
126.2 (ArC), 126.6 (ArC), 127.0 (ArC), 127.1 (ArC), 127.2 
(ArC), 127.9 (ArC), 128.0 (ArC), 128.5 (ArC), 128.6 (ArC), 
128.8 (ArC), 129.7 (ArC), 130.3 (ArC), 131.0 (ArC), 131.6 
(ArC), 143.4 (ArC), 147.2 (ArC), 154.8 (ArC), 155.1 (ArC) 
and 167.7 (CO) ppm. FABMS: m/z: 1455.4 (M+). 
C84H82N10O6S4 (1455.8): calcd C 69.30, H 5.68, N 9.62. 
Found: C 69.45, H 5.58, N 9.45. 
4.2.2. Synthesis of receptor 5a. To compound 4 (100 mg, 
0.0687 mmol) in THF (10 mL) was added phenyl isocyanate 
(45 mg, 0.275 mmol) and the mixture was stirred at room 
temperature for 24 h under argon. The resulting precipitate 
was collected by filtration, washed with methanol to give 
receptor 5a as a pale yellow solid. Recrystallization from 
chloroform–hexane (3:1) gave receptor 5a (154 mg, 83 %) as 
a pale yellow solid. M.p. 202–203 °C. IR: Xmax (KBr)/cm-1: 
3301, 2961, 2867, 1680, 1604, 1544, 1510, 1451, 1430, 
1312, 1264, 1220, 1085, 1044, 842, 815, 708 and 506. 1H 
NMR (400 MHz, CDCl3–DMSO, 10:1): δ = 0.97 (18H, s, 
tBu × 2), 1.04 (18H, s, tBu × 2), 4.22 (4H, s, OCH2–triazole 
× 2), 4.94 (4H, s, OCH2CO × 2), 6.29 (4H, s, CH2–pyrene × 
2), 6.72 (2H, s, Triazole–H × 2), 6.90–7.47 (10H, m, 
Phenyl–H × 10), 7.12 (4H, s, Ar–H × 2), 7.30 (4H, s, Ar–H × 
2), 7.54 (2H, s, NH × 2) and 7.81–8.39. (22H, m, Pyrene–H 
× 18 and NH × 4) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10:1): δ =  30.6 (CH3), 30.8 (CH3), 34.1 (C(CH3)3), 
51.9 (CH2), 62.8 (OCH2), 69.1 (OCH2), 118.6 (ArC), 118.7 
(ArC), 122.1 (ArC), 122.3 (ArC), 122.4 (ArC), 123.2 (ArC), 
124.3 (ArC), 125.6 (ArC), 125.8 (ArC), 126.1 (ArC), 126.3 
(ArC), 127.1 (ArC), 127.3 (ArC), 127.7 (ArC), 128.0 (ArC), 
128.6 (ArC), 128.8 (ArC), 128.9 (ArC), 130.4 (ArC), 130.7 
(ArC), 131.0 (ArC), 131.9 (ArC), 138.9 (ArC), 139.6 (ArC), 
143.2 (ArC), 146.9 (ArC), 148.1 (ArC), 144.4 (ArC), 153.4 
(ArC), 154.9 (CO), 155.3 (ArC) and 167.4 (CO) ppm. 
FABMS: m/z: 1693.5 (M+). C98H92N12O8S4 (1694.11): calcd 
C 69.48, H 5.47, N 9.92. Found: C 69.56, H 5.35, N 9.79. 
4.2.3. Synthesis of receptor 5b. To compound 4 (100 mg, 
0.0687 mmol) in THF (10 mL) was added p–tolyl isocyanate 
(37 mg, 0.275 mmol) and the mixture was stirred at room 
temperature for 24 h under argon. The resulting precipitate 
was collected by filtration, washed with hexane to give 
receptor 5b as a pale yellow solid. Recrystallization from 
chloroform–hexane (3:2) gave receptor 5b (88 mg, 75 %) as 
a pale yellow solid. M.p. 205–206 °C. IR: Xmax (KBr)/cm-1: 
3303, 2961, 2869, 1681, 1604, 1543, 1515, 1451, 1432, 
1314, 1266, 1229, 1087, 1045, 847, 817, 708 and 507. 1H 
NMR (400 MHz, CDCl3–DMSO, 10:1): δ = 0.97 (18H, s, 
tBu × 2), 1.02 (18H, s, tBu × 2), 2.27 (6H, s, CH3 × 2), 4.26 
(4H, s, OCH2–triazole × 2), 4.95 (4H, s, OCH2CO × 2), 6.32 
(4H, s, CH2–pyrene × 2), 6.74 (2H, s, Triazole–H × 2), 6.98 
(4H, d, Ј = 7.7 Hz, Phenyl–H × 4), 7.14 (4H, s, Ar–H × 2), 
7.17 (4H, d, Ј = 7.7 Hz, Phenyl–H × 4), 7.31 (4H, s, Ar–H × 
2), 7.54 (2H, s, NH × 2) and 7.86–8.36. (22H, m, Pyrene–H 
× 18 and NH × 4) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10:1): δ = 21.7 (CH3), 31.6 (CH3), 31.8 (CH3), 34.9 
(C(CH3)3), 52.3 (CH2), 64.0 (OCH2), 70.0 (OCH2), 119.8 
(ArC), 119.9 (ArC), 123.1 (ArC), 124.0 (ArC), 124.1 (ArC), 
125.1 (ArC), 125.3 (ArC), 126.1 (ArC), 126.6 (ArC), 126.9 
(ArC), 127.5 (ArC), 127.7 (ArC), 128.1 (ArC), 128.4 (ArC), 
129.0 (ArC), 129.4 (ArC), 129.7 (ArC), 130.0 (ArC), 131.2 
(ArC), 131.6 (ArC), 131.7 (ArC), 131.8 (ArC), 132.2 (ArC), 
137.8 (ArC), 143.8 (ArC), 148.0 (ArC), 148.6 (ArC), 155.6 
(ArC), 155.9 (ArC), 156.4 (ArC), 157.0 (CO) and 168.0 
(CO) ppm. FABMS: m/z: 1721.5 (M+). C100H96N12O8S4 
(1722.17): calcd C 69.74, H 5.64, N 9.76. Found: C 69.58, H 
5.54, N 9.67. 
4.2.4. Synthesis of receptor 5c. To compound 4 (100 mg, 
0.0687 mmol) in THF (10 mL) was added p-nitrophenyl 
isocyanate (45 mg, 0.275 mmol) and the mixture was stirred 
at room temperature for 24 h under argon. The resulting 
precipitate was collected by filtration, washed with methanol 
to give receptor 5c as a yellow solid. Recrystallization from 
chloroform–acetonitrile (3:1) gave receptor 5c (154 mg, 83 
%) as white solid. M.p. 204–207 °C. IR: Xmax (KBr)/cm-1: 
3366, 3338, 2961, 1733, 1597, 1554, 1508, 1433, 1330, 
1302, 1248, 1201, 1178, 1113, 1087, 848 and 752. 1H NMR 
(400 MHz, CDCl3–DMSO, 10:1): δ = 0.95 (18H, s, tBu × 2), 
1.04 (18H, s, tBu × 2), 4.32 (4H, s, OCH2–triazole × 2), 4.95 
(4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 6.72 
(2H, s, Triazole–H × 2), 7.12 (4H, s, Ar–H × 2), 7.33 (4H, s, 
Ar–H × 2), 7.49 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.63 
(4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.66 (2H, s, NH × 2), 
7.87–8.33. (18H, m, Pyrene–H × 18), 8.50 (2H, s, NH × 2) 
and 8.98 (2H, s, NH × 2) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10:1): δ =  30.6 (CH3), 30.8 (CH3), 34.0 (C(CH3)3), 
51.9 (CH2), 62.7 (OCH2), 68.9 (OCH2), 117.5 (ArC), 117.7 
(ArC), 122.2 (ArC), 123.1 (ArC), 124.3 (ArC), 124.7 (ArC), 
124.9 (ArC), 125.0 (ArC), 125.6 (ArC), 125.7 (ArC), 125.8 
(ArC), 126.2 (ArC), 127.1 (ArC), 127.2 (ArC), 127.5 (ArC), 
128.0 (ArC), 128.4 (ArC), 128.6 (ArC), 128.9 (ArC), 130.4 
(ArC), 130.7 (ArC), 131.0 (ArC), 131.7 (ArC), 142.0 (ArC), 
143.1 (ArC), 145.2 (ArC), 145.3 (ArC), 147.2 (ArC), 148.0 
(ArC), 154.4 (ArC), 154.9 (CO) and 167.4 (CO) ppm. 
FABMS: m/z: 1783.6 (M+). C98H90N14O12S4 (1784.1): calcd 
C 65.97, H 5.08, N 10.99. Found: C 65.78, H 5.51, N 10.82. 
4.3. Determination of the Association Constants 
The association constants were determined by using 1H 
NMR titration experiments in a constant concentration of 
host receptor (4.0 × 10–3 M) by varying the guest 
concentration (0–8.0 × 10–3 M). The 1H NMR chemical shift 
of the urea protons (NH) signal was used as a probe. The 
association constant (Ka) for the complexes of receptor 5a~c 
were calculated by nonlinear curve-fitting analysis of the 
observed chemical shifts of the NH protons according to the 
literature procedure.14 
4.4. 1H NMR Titration Experiments 
A solution of Bu4NX (X = F, Cl, Br, I, AcO, PhCOO, 
H2PO4) in CD3CN (4.0 × 10-3 M) was added to a CDCl3–
DMSO (10:1, v/v) solution of receptor 5a~c in the absence or 
presence of AgSO3CF3 in an NMR tube. 1H NMR spectra 
were recorded after addition of the reactants and the 
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temperature of the NMR probe was kept constant at 27 °C. 
The 1H NMR data of the most-representative complexes are 
given below: 
receptor 5aAg+: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.52 (4H, br, CH2–triazole  × 2), 
4.94 (4H, s, OCH2CO × 2), 6.29 (4H, s, CH2–pyrene × 2), 
7.13 (4H, s, Ar–H × 2), 7.34 (4H, s, Ar–H × 2), 7.54 (2H, br, 
NHc × 2), 7.68 (2H, s, Triazole–H  × 2) and  7.79–8.38. 
(18H, m, Pyrene-H × 18) ppm. 
receptor 5bAg+: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.56 (4H, br, CH2–triazole  × 2), 
5.00 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 
7.07 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.12 (4H, s, Ar–H × 
2), 7.30 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.48 (4H, s, Ar–
H × 2), 7.90 (2H, br, NHc × 2), 7.95 (2H, s, Triazole–H  × 2) 
and  8.00–8.41. (18H, m, Pyrene-H × 18) ppm. 
receptor 5cAg+: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.52 (4H, br, CH2–triazole  × 2), 
4.95 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 
7.12 (4H, s, Ar–H × 2), 7.50 (4H, s, Ar–H × 2), 7.63 (4H, d, 
Ј = 8.8 Hz, Phenyl–H × 4), 7.69 (4H, d, Ј = 8.8 Hz, Phenyl–
H × 4), 7.70 (2H, br, NHc × 2), 7.80 (2H, s, Triazole–H  × 2), 
8.02–8.30. (18H, m, pyrene-H × 18), 8.45 (2H, br, NHb × 2) 
and 8.98 (2H, br, NHa × 2) ppm. 
receptor 5cCl–: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.32 (4H, br, CH2–triazole  × 2), 
5.00 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 
6.72 (2H, s, triazole–H  × 2), 7.12 (4H, s, Ar–H × 2), 7.33 
(4H, s, Ar–H × 2), 7.49 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 
7.63 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.70 (2H, br, NHc × 
2), 7.87–8.33. (18H, m, Pyrene-H × 18), 8.41 (2H, br, NHb × 
2) and 9.62 (2H, br, NHa × 2) ppm. 
Ag+ ⊂ [receptor 5cCl–]: 1H NMR (300 MHz, CDCl3–
DMSO–CD3CN, 10:1:1, v/v): δ = 4.50 (4H, br, CH2–triazole  
× 2), 5.00 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 
2), 7.12 (4H, s, Ar–H × 2), 7.48 (4H, s, Ar–H × 2), 7.63 (4H, 
d, Ј = 8.8 Hz, Phenyl–H × 4), 7.69 (4H, d, Ј = 8.8 Hz, 
Phenyl–H × 4), 7.86 (2H, br, NHc × 2), 7.94 (2H, s, 
Triazole–H  × 2), 8.02–8.30. (18H, m, Pyrene-H × 18), 8.44 
(2H, br, NHb × 2) and 9.60 (2H, br, NHa × 2) ppm. 
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1. Introduction 
The investigation of macrocycles such as calix[n]arenes1 
which are attractive building blocks for creating host systems 
capable of selectively recognizing cation, anion or neutral 
molecules has become an active area of research in 
supramolecular chemistry. Thiacalix[4]arenes2,3 which are 
sulfur–bridged analogs of calix[4]arenes are excellent scaffolds 
and have been utilized in chemosensors, supramolecular self-
assemblies and the catalytic activity of enzymes. A large 
number of enzymes have allosteric sites to control catalytic 
activity by stabilizing the active conformation. Many systems 
based on thiacalix[4]arenes are capable of host–guest 
interactions and involve conformational changes caused by the 
allosteric binding4 of metal cations, and these relate to the 
maintenance of the essential material balance necessary for life. 
Anions also have been widely employed in biological, 
environmental and industrial processes.5 The development of 
anion selective sensors6 based on calix[n]arenes has received a 
considerable amount of attention in the area of supramolecular 
chemistry. Calix[n]arene urea derivatives are extremely 
prominent and are efficient for anion complexations via the N– 
 
* Corresponding author. Fax: +81 952 28 8548; e-mail address: yamatot@cc.saga-u.ac.jp        
(T. Yamato). 
H protons due to the formation of hydrogen bonds.7,8 Click 
chemistry9 is one of the most useful and widely employed 
reactions in synthetic chemistry. In particular, the Cu(I)–
catalyzed azide–alkyne cycloaddition reaction is a highly 
versatile method which can be performed in high yield under 
very mild conditions. The 1,4–disubstituted–1,2,3–triazole 
products can act as relatively stable functional groups as 
covalent linkers or as ligands for metal cations, and have been 
utilized in the fields of drug discovery and materials science. 
Recently, many calix[n]arene derivatives bearing 1,4–
disubstituted–1,2,3–triazoles as linking groups have been 
developed and investigated.10 
Chung11 and co–workers reported a fluorescent 
chemosensor bearing a calix[4]arene in a 1,3–alternate 
conformation, which contains two anthracene–appended 
triazole rings and the crown–ether moiety.11a This receptor 
exhibited a negative allosteric effect between the Pb2+ and K+ 
ions in common organic solvents. Moreover, they also reported 
that a homobinuclear ditopic fluorescent chemosensor bearing a 
1,3-alternate calix[4]arene, which contained two anthracene–
appended triazole rings and two phenylenaminones at the 
opposite sides of the calix[4]arene cavity.11d This receptor 
exhibited a positive allosteric effect between two equivalents of 
Ag+ ion in common organic solvents. However, investigations 
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concerning the appearance of allosteric effects in analogues 
based on thiacalix[4]arenes/metal cations/anions has not yet 
been reported. Herein, we have independently designed a 
heterodimeric system12 based on a thiacalix[4]arene having two 
different side arms. Specifically, we have incorporated two 
ureas moieties which link various phenyl groups substituted 
with the electron–donating or –withdrawing groups at the p–
positions and two pyrene–appended triazole rings at the 
opposite side of thiacalix[4]arene cavity. We built up the 
hypothesis that the heterodimeric system, which is controlled by 
the complexation of the opposite side arms with Cl– and Ag+ 
ions, exhibits an effective positive allosteric effect. 
2. Results and discussion 
2.1. Synthesis 
O-Alkylation of distal-1 was carried out with 10 equiv. of  
propargyl bromide in the presence of 10 equiv. of Cs2CO3 according 
to the reported procedure to afford the desired 1,3–alternate–2 in 
85 % yield.12 A Cu(I)–catalyzed 1,3–dipolar cycloaddition reaction 
of 1,3–alternate–2 with 4 equiv. of 1–azidomethylpyrene via Click 
chemistry was carried out according to the reported procedure, and 
afforded the 1,2,3–triazole thiacalix[4]arene 1,3–alternate–3 in 48 % 
yield. The hydrazinolysis of 1,3–alternate–3 was carried out with a 
large excess of hydrazine hydrate to afford the desired 1,3–
alternate–4 in 86 % yield. The condensation of 1,3–alternate–4 with 
4 equiv. of the appropriate isocyanate in THF furnished the receptors 
5a~c in good yield (Scheme 1). In general, the 1H NMR spectra of 
receptors 5a~c in CDCl3–DMSO (10:1, v/v) exhibited the 
characteristics of a 1,3–alternate canformation, viz two singlets (18H 
each) for the tert-butyl protons, one singlet (4H) for OCH2CO 
protons, one singlet (4H) for OCH2–triazole protons, two singlets 
(4H each) for aromatic protons, two singlets (2H each) for four urea 
NH protons and one singlet (2H) for triazole–H protons. Moreover, a 
concentration dependence of the 1H NMR chemical shifts of the 
ureido protons in receptor 5c was not observed (Figure S13). This 
result suggests that receptor 5c has a strong intramolecular hydrogen  
 
 
Scheme 1 Synthesis of receptors 1,3-alternate-5a~c. 
Table 1 Association constantsa of  receptor 5a~c with Cl– ionb                                       
a Measured in CH2Cl2–DMSO (10:1, v/v) at 27 °C by fluorescence 
titration experiments (Figures S15–S21); host concentration was 1.0 
μM. b Guests used: Bu4NCl. 
 
 
bond between the two ureas moieties.  
 
2.2. Binding studies 
Upon addition of Cl– ion (0–20 PM) to a solution of receptor 5c 
(1.0 PM), Figure S19 shows that both the monomer and excimer 
emissions of the pyrene units gradually decrease. A   Job’s   plot  
binding between receptor 5c and Cl– ion reveals a 1:1 stoichiometry 
(Figure S20), while the association constant (Ka value) for the 
complexation with Cl– ion by receptor  5c was determined to be 
42500 ± 2975 M-1 as determined by the fluorescence titration 
experiment in CH2Cl2–DMSO (10:1, v/v) (Figure S21 and Table 1). 
Moreover, Ka values between the receptors 5a~b and Cl– ion were 
determined by analyzing fluorescence titration experiments, 
respectively (Figures S15–S18 and Table 1). These results suggest 
that the association constants depend on the electron–
donating/withdrawing groups located at the p–position. In the 
presence of the electron–withdrawing group NO2 (receptor 5c), the 
Ka value was greater than that for the unsubstituted receptor (receptor 
5a). In contrast, in the case of receptor 5b, with the electron–donating 
Me group, there was a general decrease in the Ka value for the 
complexation with Cl– ion in comparison to the case in the 
unsubstituted receptor 5a. Therefore, the introduction of electron–
withdrawing groups at the p–position appears to increase the acidity 
of the urea protons, and hence enhance the anion–binding ability 
through hydrogen–bonding interactions. The Ka value of receptor 5c 
with the electron–withdrawing NO2 group at the p–position was the 
best out of all the Ka values between receptors 5a~c and Cl– ion. From  
 
 
 
Fig. 1 Fluorescence spectral changes of receptor 5c (1.0 PM) upon addition of 
various tested anions (1.0  μM)  in  CH2Cl2–DMSO  (10:1,  v/v).  λex = 343 nm. 
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Fig. 2 Binding mode of receptor 5c upon addition of Cl– ion at 298 K as a 
tetrabutylammonium (TBA) salt and partial 1H NMR spectra of 5c (4.0 mM) 
in CDCl3–DMSO–CH3CN (10:1:1, v/v) upon addition of Ag+ ion at 298 K. 
 
 
the above, we can say that the receptor 5c, with the electron– 
withdrawing NO2 group at the p–position, has the most effective 
recognition ability toward selected anions of the systems screened 
herein. Given this, complexation studies of receptor 5c toward 
targeting various transition metal cations and anions were carried out 
using 1H NMR and UV–vis spectroscopy and by fluorescence 
titration experiments.  
The UV–vis absorption spectra of receptor 5c (1.0 μM) were 
recorded in the presence of various anions (20 equiv.) in CH2Cl2–
DMSO (10:1, v/v) as shown in Figure S14. The receptor 5c (1.0 
μM)exhibits an absorption band at 347 nm in the UV–vis absorption 
spectra in the absence of anions. Interestingly, significant changes 
moving to a longer wavelength in absorption spectra were observed 
in the presence of F–, AcO–, PhCOO– or H2PO4– with a color change 
from colourless to dark yellow by the naked eye, respectively. These 
results suggest that the quinoid structure was formed by the 
deprotonation of the urea NH groups in the p–nitrophenyl ureido 
moiety. Figure 1 reveals the fluorescence intensity changes of the 
monomer (393 nm) and excimer (486 nm) emissions for receptor 5c 
in the presence of various anions. Receptor 5c exhibited a decrease in 
intensity of both the monomer and excimer emissions with various 
anions. Upon addition of Cl– ion to a solution of receptor 5c, the 
decrease of intensity of the monomer emission is presumably caused 
by a photo–induced electron transfer (PET) mechanism which  
Fig. 3 Fluorescence spectral changes of receptor 5c (1.0 PM) to upon addition 
of various tested metal cations (20  μM)  in  CH2Cl2–DMSO  (10:1,  v/v).  λex = 
343 nm. 
 
 
Fig. 4 Fluorescence response of receptor 5c (1.0 PM) in CH2Cl2–DMSO (10:1, 
v/v) to various tested metal cations (20  μM)  (blue bar) and to the mixture of 
tested metal ions (20  μM)  with  Ag+ ion (20  μM)  (red bar) at 298 K. Io is the 
fluorescence intensity at 393 nm for free receptor 5c, and I is the fluorescence 
intensity after adding metal ions with an excitation at 343 nm. 
 
 
operates from the oxygen of the urea moiety which complexes with 
the Cl– ion via hydrogen bonding to the pyrene moieties. By contrast, 
upon addition of F–, AcO–, PhCOO– or H2PO4– ions to a solution of 
receptor 5c, the decreasing intensity of the monomer emission is 
caused by deprotonation of the urea NH groups which induces a PET 
mechanism from the anionic nitrogen to the pyrene moieties. On the 
other hand, upon addition of F–, Cl–, AcO–, PhCOO– or H2PO4– ions 
to a solution of receptor 5c, the decreasing intensity of the excimer 
emission is caused by conformational unstacking of two pyrene ureas, 
which   breaks   down   an   intramolecular   π–π   interaction because of 
complex formation. As shown in Figure 2, the signals for the NHa 
protons (red) progressively shifted downfield by 0.64 ppm (δ = 8.98 
to 9.62 ppm) until one equiv. of Cl– ion was added. On the other 
hand, the signals for the NHb protons (blue) progressively shifted 
upfield by 0.09 ppm (δ = 8.50 to 8.41 ppm) until one equiv. of Cl– 
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Fig. 5 Binding mode of receptors 5c upon complexation with Ag+ ion as 
trifluoromethanesulforic salt, and partial 1H NMR spectra of receptors 5c (4.0 
mM) in CDCl3–DMSO–CD3CN (10:1:1, v/v) upon addition of Ag+ ion (1.0 
equiv.) at 298 K. 
 
 
ion was added. These results strongly suggested Cl– ion recognition 
by receptor 5c via a hydrogen–bonding interaction between Cl– ion 
and N–H protons as shown in Figure 2 and Figure S32. The 
fluorescence intensity changes of receptor 5c were recorded in 
CH2Cl2–DMSO (10:1, v/v) in the presence of a 20–fold excess of 
various metal cations and their fluorescence spectra thus obtained 
were compared with that recorded in the absence of metal cations 
under similar experimental conditions. It was observed that both the 
monomer and excimer emissions of receptor 5c were strongly 
quenched by Cu2+ and Hg2+ ions in Figure 3. The fluorescence 
titration behaviour was evaluated in the case of receptor 5c with Cu2+ 
and Hg2+ ions (Figures S22–S25). From these observations, the 
association constants for complexation were calculated to be: 5c·Cu2+ 
= 330000±23100 M-1, 5c·Hg2+ = 420000±29400 M-1, respectively. 
In contrast, upon addition of Ag+ ion into a solution of receptor 5c, 
the fluorescence monomer emission was enhanced, while the 
excimer emission decreased. As shown in Figue 4, competitive 
experiments were carried out in the presence of Ag+ ion   (20   μM)  
mixed with other metal cations (20  μM). These results suggested that 
the receptor 5c exhibits selective fluorescent behaviour towards the 
Ag+ ion. Upon addition of Ag+ ion (0–20 PM) to a solution of 
receptor 5c (1.0 PM), Figure S26 shows the excimer emission of the 
pyrene units (486 nm) dicreases and the monomer emission of the 
pyrene units (393 nm) increases. This is because the complexation of 
Ag+ ion by receptor 5c induces the conformational unstacking of two 
pyrene ureas resulting in quenching   of   an   intramolecular   π–π  
interaction. Meanwhile, a discernible isoemissive point was observed 
at 445 nm. A   Job’s   plot   binding   between   receptor   5c and Ag+ ion 
reveals a 1:1 stoichiometry (Figure S27), while the association 
constant (Ka) for the complexation with Ag+ ion by receptor  5c was 
determined to be 61975 ± 4336 M-1 as determined by the 
fluorescence titration experiment in CH2Cl2–DMSO (10:1, v/v) 
(Figure S28). The fluorescent titration profile for receptor 5c with 
Ag+ ion demonstrated that the detection limit of Ag+ ion was 1.92 × 
10-7 M (Figure S29). As a result, receptor 5c can be regarded as being 
highly sensitive to the Ag+ ion, especially given the large 
fluorescence dynamic range and the low detection limit of 1.92 × 10-
7 M. The quantum yield of the free receptor 5c is  Φ  =  0.11, for both 
the monomer and excimer emission (393 and 486 nm). The quantum 
yield of the receptor 5c•Ag+ complex   is   Φ   =   0.06 as a result of 
increased monomer emission. To elucidate the complexation 
behaviour of receptors 5c with Ag+ ion in detail, 1H NMR 
spectroscopic titration experiments in CDCl3–DMSO–CH3CN 
(10:1:1, v/v) were carried out. Upon addition of 1.0 equiv. of Ag+ ion 
to the solution of receptors 5c, a large downfield shift of 1.08 ppm (δ 
= 6.72 to 7.80 ppm) for the proton Hh on the triazole ring was 
observed, together with a downfield shift of 0.20 ppm (δ = 4.32 to 
4.52 ppm) for the proton Hg on the OCH2-triazole unit and a 
downfield shift of 0.17 ppm (δ = 7.33 to 7.50 ppm) for the proton Hf 
on the aromatic protons of thiacalix[4]arene cavity; the chemical 
shifts of the NH protons did not change. This result suggested that 
the Ag+ ion can be selectively bound by the nitrogen atoms on the 
triazole rings and is included   in   the   π–basic benzene cavity at the 
lower rim. The two distal benzene rings were flattened and the 
residual two benzene rings were standing upright for the binding of 
the Ag+ ion as shown in Figure 5. On the basis of the above, we 
investigated the appearance of an allosteric effect by the 
complexation of the opposite side arms with Cl– and Ag+ ions by 1H 
NMR spectroscopic and fluorescence titration experiments. The 
result of the fluorescence titration experiments of receptor 5c• Cl– 
with Ag+ ion are shown in Figure S33. When increasing 
concentrations of Ag+ ion were added to a solution of receptor 5c•
Cl–, the fluorescence intensity of the monomer (393 nm) and excimer 
(486 nm) emissions of pyrene gradually increased because of an 
allosteric effect via an ion-pair electrostatic interaction and a 
conformational change of the flexible thiacalix[4]arene cavity. 
Further addition of more than 1.0 equiv. of Ag+ ion led to a 
significant increase in the monomer emission of the pyrene units, 
while the accompanying excimer emission reached a plateau upon 
adding about 20 equiv of Ag+ ion. The association constant of 
receptor 5c• Cl– with Ag+ ion was determined to be 325000±22750 
M-1 by the fluorescence titration experiment in CH2Cl2–DMSO (10:1, 
v/v) (Figure S34). The results indicated that receptor 5c• Cl– was 
complexed with the Ag+ ion at two pyrene–appended triazole 
rings by a positive allosteric effect because the complexation with 
Cl– ion in the urea cavity caused an ion-pair electrostatic interaction 
and a conformational change of the flexible thiacalix[4]arene cavity. 
The fluorescent titration profile for receptor 5c• Cl– with Ag+ ion 
demonstrated that the detection limit of Ag+ ion was 1.02 × 10-8 M 
(Figure S35). As a result, in comparison to the case in the free 
receptor 5c to the Ag+ ion (1.92 × 10-7 M), receptor 5c• Cl– can be 
regarded as being more highly sensitive to the Ag+ ion. To 
investigate further the possible appearance of an effective allosteric 
effect between receptor 5c• Cl– and the Ag+ ion, 1H NMR titration 
experiments in CDCl3–DMSO–CD3CN (10:1:1, v/v) were conducted. 
When only Cl– ion was added, it was observed that the signal for the 
NHa protons shifted downfield, while the signal for NHb protons 
shifted upfield. However, the signals of the protons on the two 
pyrene–appended triazole ring moieties did not shift (Figures 6a 
and 6b). This result suggests a Cl– ion recognition of receptor 5c by a 
hydrogen–bonding interaction between the Cl– ion and N–H protons.  
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Fig. 6 Proposed positive allosteric behaviour of receptor 5c with Cl– and Ag+ 
ions. Partial 1H NMR spectra of 5c /guest (H/G = 1:1); a) free 5c; b) 
5cBu4NCl; c) AgSO3CF3[5cCl–]; d) 5cAgSO3CF3. Solvent: CDCl3–
DMSO–CD3CN (10:1:1, v/v). 300 MHz at 298 K. *Denoted the solvent peak. 
 
 
Furthermore, when Ag+ ion was added to a solution of [5cBu4NCl] 
(Figure 6c), this addition induced a large downfield shift of 1.22 ppm 
(δ = 6.72 to 7.94 ppm) for the proton Hh on the triazole ring, a 
downfield shift of 0.18 ppm (δ = 4.32 to 4.50 ppm) for the proton Hg 
on the OCH2–triazole unit and a downfield shift of 0.15 ppm (δ = 
7.33 to 7.48 ppm) for the proton Hf of the aromatic protons of 
thiacalix[4]arene cavity. The chemical shifts for all NH protons did 
not change. These results suggested the formation of a heterogeneous 
dinuclear complex Ag+[5cCl–] (Figure 6c), and we propose a 
positive allosteric effect for receptor 5c toward the Ag+ ion in the 
presence of the Cl– ion as shown in Figure 6.  
3. Conclusion 
In summary, the novel heteroditopic receptors 5a~c bearing a 
thiacalix[4]arene in a 1,3–alternate conformation have been 
synthesized. These receptors possess two ureas moieties linking 
various aryl groups bearing electron–donating or –withdrawing 
substituents at their p–positions which act as anion–binding 
sites and two pyrene–appended triazole rings which act as 
cation–binding sites at the opposite side of thiacalix[4]arene 
cavity. Furthermore, we have shown that two ureas moieties can 
bind various anions having a wide range of geometries based on 
UV–vis absorption, fluorescence and 1H NMR titration experiments. 
We have also shown that the triazole groups can bind Ag+, Hg2+ and 
Cu2+ ions based on both fluorescence spectroscopy and 1H NMR 
titration experiments. Upon addition of Hg2+ and Cu2+ ions to a 
solution of receptor 5c in CH2Cl2–DMSO (10:1, v/v), the 
fluorescence spectrum was strongly quenched because of a reverse 
PET from the pyrene moieties to the triazole groups. By contrast, 
upon addition of Ag+ ion to a solution of receptor 5c in CH2Cl2–
DMSO (10:1, v/v), the fluorescence monomer emission was 
enhanced, while the excimer emission declined because of the 
complexation of the Ag+ ions with the triazole groups. Interestingly, 
the fluorescence of receptor 5c was quenched by Cl– ion, but could 
be revived by the addition of Ag+ ion to the receptor 5c• Cl– 
complex. The appearance of a positive allosteric effect in receptor 5c 
was investigated based on fluorescence and 1H NMR titration 
experiments. Interestingly, the formation of heterogeneous dinuclear 
complex Ag+[5cCl–] of receptor 5c with Cl– and  Ag+ ions by a 
positive allosteric effect could be observed.  
 
4. Experimental section 
4.1 General  
Unless otherwise stated, all reagents used were purchased 
from commercial sources and were used without further 
purification. Compounds 1,13 212e and 312e were prepared 
following the reported procedures. All solvents used were dried 
and distilled by the usual procedures prior to use. All melting 
points (Yanagimoto MP-S1) are uncorrected. 1H NMR and 13C 
NMR spectra were recorded on a Nippon Denshi JEOL FT-300 
NMR spectrometer and Varian-400MR-vnmrs400 with SiMe4 as 
an internal reference: J-values are given in Hz. IR spectra were 
measured for samples as KBr pellets on a Nippon Denshi JIR-
AQ2OM spectrophotometer. Mass spectra were obtained with a 
Nippon Denshi JMS-HX110A Ultrahigh Performance mass 
spectrometer at 75 eV by using a direct-inlet system. UV-vis 
spectra were recorded using a Shimadzu UV-3150UV-vis-NIR 
spectrophotometer. Fluorescence spectroscopic studies of 
compounds in solution were performed in a semimicro 
fluorescence cell (Hellma®, 104F-QS, 10 × 4 mm, 1400  μL)  with  
a Varian Cary Eclipse spectrophotometer. Fluorescence quantum 
yields were recorded in solution (Hamamatsu Photonics K. K. 
Quantaurus-QY A10094) using the integrated sphere absolute PL 
quantum yield measurement method. Elemental analyses were 
performed by a Yanaco MT-5.The elemental analysis, MS, and 
emission spectra were measured. 
4.2. Materials 
4.2.1. Synthesis of compound 4. Compound 3 (300 mg, 
0.202 mmol) was put into a round-bottom flask and ethanol 
(50 mL), THF (50 mL) and hydrazine hydrate (6 mL, large 
excess) were added and the system was refluxed for 24 h. 
After cooling, the solvents and excess hydrazine were 
removed under reduced pressure to give the crude product as 
a white solid. The residue was triturated sequentially with 
water and methanol and the product collected by filtration. 
The residue was adsorbed in silica gel and purified by 
column chromatography using ethyl acetate as eluent and 
washed with hexane to give receptor 4a (253 mg, 86 %) as a 
white solid. M.p. 157–161 °C. IR: Xmax (KBr)/cm-1: 3422, 
3322, 2869, 1677, 1623, 1590, 1432, 1381, 1362, 1266, 
1239, 1087, 1045, 970, 817 and 708. 1H NMR (400 MHz, 
CDCl3): δ = 0.95 (18H, s, tBu × 2), 0.99 (18H, s, tBu × 2), 
3.49 (4H, br, NH2 × 2), 4.29 (4H, s, OCH2–triazole × 2), 5.06 
(4H, s, OCH2CO × 2), 6.29 (4H, s, CH2–pyrene × 2), 6.69 
(2H, s, Triazole–H × 2), 7.07 (4H, s, Ar–H × 2), 7.26 (4H, s, 
Ar–H × 2), 7.36 (2H, s, NH × 2) and  7.86–8.33. (18H, m, 
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Pyrene–H × 18) ppm. 13C NMR (100 MHz, CDCl3): δ = 
30.7 (CH3), 30.8 (CH3), 33.9 (C(CH3)3), 51.8 (CH2), 62.6 
(OCH2), 68.3 (OCH2), 122.2 (ArC), 122.9 (ArC), 124.2 
(ArC), 124.6 (ArC), 124.7 (ArC), 125.5 (ArC), 125.6 (ArC), 
126.2 (ArC), 126.6 (ArC), 127.0 (ArC), 127.1 (ArC), 127.2 
(ArC), 127.9 (ArC), 128.0 (ArC), 128.5 (ArC), 128.6 (ArC), 
128.8 (ArC), 129.7 (ArC), 130.3 (ArC), 131.0 (ArC), 131.6 
(ArC), 143.4 (ArC), 147.2 (ArC), 154.8 (ArC), 155.1 (ArC) 
and 167.7 (CO) ppm. FABMS: m/z: 1455.4 (M+). 
C84H82N10O6S4 (1455.8): calcd C 69.30, H 5.68, N 9.62. 
Found: C 69.45, H 5.58, N 9.45. 
4.2.2. Synthesis of receptor 5a. To compound 4 (100 mg, 
0.0687 mmol) in THF (10 mL) was added phenyl isocyanate 
(45 mg, 0.275 mmol) and the mixture was stirred at room 
temperature for 24 h under argon. The resulting precipitate 
was collected by filtration, washed with methanol to give 
receptor 5a as a pale yellow solid. Recrystallization from 
chloroform–hexane (3:1) gave receptor 5a (154 mg, 83 %) as 
a pale yellow solid. M.p. 202–203 °C. IR: Xmax (KBr)/cm-1: 
3301, 2961, 2867, 1680, 1604, 1544, 1510, 1451, 1430, 
1312, 1264, 1220, 1085, 1044, 842, 815, 708 and 506. 1H 
NMR (400 MHz, CDCl3–DMSO, 10:1): δ = 0.97 (18H, s, 
tBu × 2), 1.04 (18H, s, tBu × 2), 4.22 (4H, s, OCH2–triazole 
× 2), 4.94 (4H, s, OCH2CO × 2), 6.29 (4H, s, CH2–pyrene × 
2), 6.72 (2H, s, Triazole–H × 2), 6.90–7.47 (10H, m, 
Phenyl–H × 10), 7.12 (4H, s, Ar–H × 2), 7.30 (4H, s, Ar–H × 
2), 7.54 (2H, s, NH × 2) and 7.81–8.39. (22H, m, Pyrene–H 
× 18 and NH × 4) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10:1): δ =  30.6 (CH3), 30.8 (CH3), 34.1 (C(CH3)3), 
51.9 (CH2), 62.8 (OCH2), 69.1 (OCH2), 118.6 (ArC), 118.7 
(ArC), 122.1 (ArC), 122.3 (ArC), 122.4 (ArC), 123.2 (ArC), 
124.3 (ArC), 125.6 (ArC), 125.8 (ArC), 126.1 (ArC), 126.3 
(ArC), 127.1 (ArC), 127.3 (ArC), 127.7 (ArC), 128.0 (ArC), 
128.6 (ArC), 128.8 (ArC), 128.9 (ArC), 130.4 (ArC), 130.7 
(ArC), 131.0 (ArC), 131.9 (ArC), 138.9 (ArC), 139.6 (ArC), 
143.2 (ArC), 146.9 (ArC), 148.1 (ArC), 144.4 (ArC), 153.4 
(ArC), 154.9 (CO), 155.3 (ArC) and 167.4 (CO) ppm. 
FABMS: m/z: 1693.5 (M+). C98H92N12O8S4 (1694.11): calcd 
C 69.48, H 5.47, N 9.92. Found: C 69.56, H 5.35, N 9.79. 
4.2.3. Synthesis of receptor 5b. To compound 4 (100 mg, 
0.0687 mmol) in THF (10 mL) was added p–tolyl isocyanate 
(37 mg, 0.275 mmol) and the mixture was stirred at room 
temperature for 24 h under argon. The resulting precipitate 
was collected by filtration, washed with hexane to give 
receptor 5b as a pale yellow solid. Recrystallization from 
chloroform–hexane (3:2) gave receptor 5b (88 mg, 75 %) as 
a pale yellow solid. M.p. 205–206 °C. IR: Xmax (KBr)/cm-1: 
3303, 2961, 2869, 1681, 1604, 1543, 1515, 1451, 1432, 
1314, 1266, 1229, 1087, 1045, 847, 817, 708 and 507. 1H 
NMR (400 MHz, CDCl3–DMSO, 10:1): δ = 0.97 (18H, s, 
tBu × 2), 1.02 (18H, s, tBu × 2), 2.27 (6H, s, CH3 × 2), 4.26 
(4H, s, OCH2–triazole × 2), 4.95 (4H, s, OCH2CO × 2), 6.32 
(4H, s, CH2–pyrene × 2), 6.74 (2H, s, Triazole–H × 2), 6.98 
(4H, d, Ј = 7.7 Hz, Phenyl–H × 4), 7.14 (4H, s, Ar–H × 2), 
7.17 (4H, d, Ј = 7.7 Hz, Phenyl–H × 4), 7.31 (4H, s, Ar–H × 
2), 7.54 (2H, s, NH × 2) and 7.86–8.36. (22H, m, Pyrene–H 
× 18 and NH × 4) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10:1): δ = 21.7 (CH3), 31.6 (CH3), 31.8 (CH3), 34.9 
(C(CH3)3), 52.3 (CH2), 64.0 (OCH2), 70.0 (OCH2), 119.8 
(ArC), 119.9 (ArC), 123.1 (ArC), 124.0 (ArC), 124.1 (ArC), 
125.1 (ArC), 125.3 (ArC), 126.1 (ArC), 126.6 (ArC), 126.9 
(ArC), 127.5 (ArC), 127.7 (ArC), 128.1 (ArC), 128.4 (ArC), 
129.0 (ArC), 129.4 (ArC), 129.7 (ArC), 130.0 (ArC), 131.2 
(ArC), 131.6 (ArC), 131.7 (ArC), 131.8 (ArC), 132.2 (ArC), 
137.8 (ArC), 143.8 (ArC), 148.0 (ArC), 148.6 (ArC), 155.6 
(ArC), 155.9 (ArC), 156.4 (ArC), 157.0 (CO) and 168.0 
(CO) ppm. FABMS: m/z: 1721.5 (M+). C100H96N12O8S4 
(1722.17): calcd C 69.74, H 5.64, N 9.76. Found: C 69.58, H 
5.54, N 9.67. 
4.2.4. Synthesis of receptor 5c. To compound 4 (100 mg, 
0.0687 mmol) in THF (10 mL) was added p-nitrophenyl 
isocyanate (45 mg, 0.275 mmol) and the mixture was stirred 
at room temperature for 24 h under argon. The resulting 
precipitate was collected by filtration, washed with methanol 
to give receptor 5c as a yellow solid. Recrystallization from 
chloroform–acetonitrile (3:1) gave receptor 5c (154 mg, 83 
%) as white solid. M.p. 204–207 °C. IR: Xmax (KBr)/cm-1: 
3366, 3338, 2961, 1733, 1597, 1554, 1508, 1433, 1330, 
1302, 1248, 1201, 1178, 1113, 1087, 848 and 752. 1H NMR 
(400 MHz, CDCl3–DMSO, 10:1): δ = 0.95 (18H, s, tBu × 2), 
1.04 (18H, s, tBu × 2), 4.32 (4H, s, OCH2–triazole × 2), 4.95 
(4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 6.72 
(2H, s, Triazole–H × 2), 7.12 (4H, s, Ar–H × 2), 7.33 (4H, s, 
Ar–H × 2), 7.49 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.63 
(4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.66 (2H, s, NH × 2), 
7.87–8.33. (18H, m, Pyrene–H × 18), 8.50 (2H, s, NH × 2) 
and 8.98 (2H, s, NH × 2) ppm. 13C NMR (100 MHz, CDCl3–
DMSO, 10:1): δ =  30.6 (CH3), 30.8 (CH3), 34.0 (C(CH3)3), 
51.9 (CH2), 62.7 (OCH2), 68.9 (OCH2), 117.5 (ArC), 117.7 
(ArC), 122.2 (ArC), 123.1 (ArC), 124.3 (ArC), 124.7 (ArC), 
124.9 (ArC), 125.0 (ArC), 125.6 (ArC), 125.7 (ArC), 125.8 
(ArC), 126.2 (ArC), 127.1 (ArC), 127.2 (ArC), 127.5 (ArC), 
128.0 (ArC), 128.4 (ArC), 128.6 (ArC), 128.9 (ArC), 130.4 
(ArC), 130.7 (ArC), 131.0 (ArC), 131.7 (ArC), 142.0 (ArC), 
143.1 (ArC), 145.2 (ArC), 145.3 (ArC), 147.2 (ArC), 148.0 
(ArC), 154.4 (ArC), 154.9 (CO) and 167.4 (CO) ppm. 
FABMS: m/z: 1783.6 (M+). C98H90N14O12S4 (1784.1): calcd 
C 65.97, H 5.08, N 10.99. Found: C 65.78, H 5.51, N 10.82. 
4.3. Determination of the Association Constants 
The association constants were determined by using 1H 
NMR titration experiments in a constant concentration of 
host receptor (4.0 × 10–3 M) by varying the guest 
concentration (0–8.0 × 10–3 M). The 1H NMR chemical shift 
of the urea protons (NH) signal was used as a probe. The 
association constant (Ka) for the complexes of receptor 5a~c 
were calculated by nonlinear curve-fitting analysis of the 
observed chemical shifts of the NH protons according to the 
literature procedure.14 
4.4. 1H NMR Titration Experiments 
A solution of Bu4NX (X = F, Cl, Br, I, AcO, PhCOO, 
H2PO4) in CD3CN (4.0 × 10-3 M) was added to a CDCl3–
DMSO (10:1, v/v) solution of receptor 5a~c in the absence or 
presence of AgSO3CF3 in an NMR tube. 1H NMR spectra 
were recorded after addition of the reactants and the 
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temperature of the NMR probe was kept constant at 27 °C. 
The 1H NMR data of the most-representative complexes are 
given below: 
receptor 5aAg+: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.52 (4H, br, CH2–triazole  × 2), 
4.94 (4H, s, OCH2CO × 2), 6.29 (4H, s, CH2–pyrene × 2), 
7.13 (4H, s, Ar–H × 2), 7.34 (4H, s, Ar–H × 2), 7.54 (2H, br, 
NHc × 2), 7.68 (2H, s, Triazole–H  × 2) and  7.79–8.38. 
(18H, m, Pyrene-H × 18) ppm. 
receptor 5bAg+: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.56 (4H, br, CH2–triazole  × 2), 
5.00 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 
7.07 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.12 (4H, s, Ar–H × 
2), 7.30 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.48 (4H, s, Ar–
H × 2), 7.90 (2H, br, NHc × 2), 7.95 (2H, s, Triazole–H  × 2) 
and  8.00–8.41. (18H, m, Pyrene-H × 18) ppm. 
receptor 5cAg+: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.52 (4H, br, CH2–triazole  × 2), 
4.95 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 
7.12 (4H, s, Ar–H × 2), 7.50 (4H, s, Ar–H × 2), 7.63 (4H, d, 
Ј = 8.8 Hz, Phenyl–H × 4), 7.69 (4H, d, Ј = 8.8 Hz, Phenyl–
H × 4), 7.70 (2H, br, NHc × 2), 7.80 (2H, s, Triazole–H  × 2), 
8.02–8.30. (18H, m, pyrene-H × 18), 8.45 (2H, br, NHb × 2) 
and 8.98 (2H, br, NHa × 2) ppm. 
receptor 5cCl–: 1H NMR (300 MHz, CDCl3–DMSO–
CD3CN, 10:1:1, v/v): δ = 4.32 (4H, br, CH2–triazole  × 2), 
5.00 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 2), 
6.72 (2H, s, triazole–H  × 2), 7.12 (4H, s, Ar–H × 2), 7.33 
(4H, s, Ar–H × 2), 7.49 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 
7.63 (4H, d, Ј = 8.8 Hz, Phenyl–H × 4), 7.70 (2H, br, NHc × 
2), 7.87–8.33. (18H, m, Pyrene-H × 18), 8.41 (2H, br, NHb × 
2) and 9.62 (2H, br, NHa × 2) ppm. 
Ag+ ⊂ [receptor 5cCl–]: 1H NMR (300 MHz, CDCl3–
DMSO–CD3CN, 10:1:1, v/v): δ = 4.50 (4H, br, CH2–triazole  
× 2), 5.00 (4H, s, OCH2CO × 2), 6.32 (4H, s, CH2–pyrene × 
2), 7.12 (4H, s, Ar–H × 2), 7.48 (4H, s, Ar–H × 2), 7.63 (4H, 
d, Ј = 8.8 Hz, Phenyl–H × 4), 7.69 (4H, d, Ј = 8.8 Hz, 
Phenyl–H × 4), 7.86 (2H, br, NHc × 2), 7.94 (2H, s, 
Triazole–H  × 2), 8.02–8.30. (18H, m, Pyrene-H × 18), 8.44 
(2H, br, NHb × 2) and 9.60 (2H, br, NHa × 2) ppm. 
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